| Literature DB >> 22811907 |
D Popov1, R Krasteva, R Ivanova, L Mateva, Z Krastev.
Abstract
Introduction. There are limited studies on simultaneous evaluation of liver and renal blood flow using Doppler methods. We evaluated and compared the changes of liver and renal Doppler US parameters in patients with liver cirrhosis according to the degree of liver disease. Material and Methods. We assessed a large spectrum of liver and renal Doppler US parameters in 67 patients with liver cirrhosis. Results. Significant differences between Child's classes or score, as well as MELD score, were observed in all investigated intrarenal blood flow Doppler US parameters, except renal artery peak systolic velocity, but only in some of the hepatic ones. The deviations of renal Doppler US parameters were also related with the complications of liver cirrhosis, as well as serum urea and creatinine levels. There was relationship between Doppler US parameters of hepatic artery and the corresponding renal artery Doppler US parameters. The changes of Doppler US parameters were age independent. Conclusion. Our results show, renal Doppler US parameters correlate with the severity and complications of liver cirrhosis. Because of dynamic deviations of renal Doppler US parameters with advance of liver cirrhosis, we recommend Doppler US of renal artery as a part of follow up of these patients.Entities:
Year: 2012 PMID: 22811907 PMCID: PMC3397178 DOI: 10.1155/2012/961654
Source DB: PubMed Journal: Int J Nephrol
Characteristics of patients with liver cirrhosis.
| Parameters | All patients ( | Child A ( | Child B ( | Child C ( |
|---|---|---|---|---|
| Age ( | 54.22 ± 12.36 | 56.85 ± 12.26 | 51.45 ± 12.75 | 52.08 ± 11.34 |
| Sex—m/f | 39/28 | 17/16 | 14/8 | 8/4 |
| Etiology ( | ||||
| Alcohol | 25 | 5 | 10 | 10 |
| Viral | 37 | 26 | 10 | 1 |
| Study approved | 2 | 1 | 1 | — |
| Autoimmune | 3 | 1 | 1 | 1 |
| Others | ||||
| LC ( | ||||
| Compensated | 32 | 29 | 3 | 0 |
| Decompensated | 35 | 4 | 19 | 12 |
| Esophageal varices ( | ||||
| Yes/no | 49/18 | 23/10 | 14/8 | 12/0 |
| Ascites ( | ||||
| Yes/no | 26/41 | 2/31 | 13/9 | 11/1 |
| Encephalopathy ( | ||||
| Yes/no | 8/59 | 0/33 | 2/20 | 6/6 |
| MELD score ( | 15.01 ± 7.17 | 10.90 ± 3.29 | 15.32 ± 3.67 | 25.75 ± 8.64 |
| Therapy with ( | ||||
| B-blockers—Yes/no | 39/28 | 15/18 | 16/6 | 8/4 |
| Diuretics—Yes/no | 42/25 | 16/17 | 15/7 | 11/1 |
| Comorbidity ( | ||||
| Yes/no | 50/17 | 28/5 | 14/8 | 8/4 |
Liver Doppler US parameters in patients with liver cirrhosis according to Child-Pugh classification.
| Parameter | All patients ( | Child A ( | Child B ( | Child C ( | Child's score (5–15 points) |
|---|---|---|---|---|---|
| Mean ± SD | Mean ± SD | Mean ± SD | Mean ± SD | Correlation ( | |
| PVV | 16.35 ± 3.49 | 15.68 ± 3.35 | 16.49 ± 3.03 | 17.94 ± 4.32 |
0.268,
|
| PV-PSV | 28.68 ± 6.12 | 27.51 ± 5.87 | 28.93 ± 5.32 | 31.46 ± 7.59 | 0.268 |
| HA-PSV | 69.60 ± 20.55 | 70.23 ± 21.07 | 67.58 ± 16.30 | 71.56 ± 26.86 | |
| HA-MnV | 43.23 ± 12.73 | 43.49 ± 13.07 | 42.22 ± 10.09 | 44.39 ± 16.67 | |
| HA-EDV | 23.41 ± 7.13 | 22.78 ± 7.30 | 23.86 ± 6.65 | 24.33 ± 7.96 | |
| HA-RI | 0.66 ± 0.07 | 0.67 ± 0.04 | 0.64 ± 0.07 | 0.65 ± 0.10 | |
| HA-PI | 1.06 ± 0.12 | 1.09 ± 0.08 | 1.03 ± 0.13 | 1.04 ± 0.17 | |
| A/P | 2.50 ± 0.78 | 2.60 ± 0.73 | 2.39 ± 0.67 | 2.43 ± 1.08 | |
| LVI | 15.73 ± 4.37 | 14.55 ± 3.55 | 16.18 ± 3.36 | 18.13 ± 6.75 |
0.282
|
| mLVI | 25.21 ± 6.88 | 25.21 ± 6.88 | 26.04 ± 5.50 | 28.47 ± 10.60 |
Liver Doppler US parameters with significant differences according to MELD score.
| Parameter | MELD |
| Mean | SD | 95% confidence interval for mean | Minimum | Maximum |
| |
|---|---|---|---|---|---|---|---|---|---|
| Lower bound | Upper bound | ||||||||
| HA-MnV | <20 | 55 | 41.32 | 10.45 | 38.49 | 44.14 | 22.30 | 71.36 | 0.007 |
| >20 | 12 | 52.01 | 18.29 | 40.39 | 63.62 | 24.37 | 84.60 | ||
| HA-PSV | <20 | 55 | 66.49 | 16.85 | 61.93 | 71.04 | 36.00 | 115.10 | 0.007 |
| >20 | 12 | 83.85 | 29.48 | 65.12 | 102.58 | 39.30 | 136.40 | ||
| A/P | <20 | 55 | 2.41 | 0.63 | 2.24 | 2.58 | 1.15 | 4.07 | 0.029 |
| >20 | 12 | 2.95 | 1.20 | 2.18 | 3.71 | 1.01 | 4.81 | ||
Renal Doppler US parameters in patients with liver cirrhosis according to Child-Pugh classification.
| Parameter | All patients ( | Child A ( | Child B ( | Child C ( | Child's score (5–15 points) |
|---|---|---|---|---|---|
| Mean ± SD | Mean ± SD | Mean ± SD | Mean ± SD | Correlation ( | |
| RRA-PSV | 56.06 ± 11.24 | 57.47 ± 11.07 | 55.33 ± 11.07 | 53.53 ± 11.29 | |
| LRA-PSV | 55.79 ± 12.36 | 56.56 ± 13.27 | 56.69 ± 11.44 | 52.01 ± 11.62 | |
| RRA-MnV | 31.62 ± 7.36 | 32.73 ± 6.65 | 32.63 ± 7.96 | 26.70 ± 6.59 | |
| LRA-MnV | 31.10 ± 7.61 | 31.85 ± 7.79 | 32.67 ± 7.04 | 26.17 ± 6.59 | |
| RRA-EDV | 19.07 ± 5.40 | 19.88 ± 4.78 | 20.07 ± 5.66 | 15.00 ± 5.01 | −0.400 |
| LRA-EDV | 18.17 ± 5.33 | 18.60 ± 5.27 | 19.45 ± 5.04 | 14.62 ± 4.80 | −0.298 |
| RRA-RI | 0.66 ± 0.06 | 0.65 ± 0.05 | 0.64 ± 0.05 | 0.72 ± 0.09 | 0.456 |
| LRA-RI | 0.67 ± 0.07 | 0.67 ± 0.05 | 0.65 ± 0.06 | 0.71 ± 0.09 | 0.349 |
| RRA-PI | 1.21 ± 0.30 | 1.17 ± 0.17 | 1.10 ± 0.17 | 1.51 ± 0.51 | 0.532 |
| LRA-PI | 1.23 ± 0.27 | 1.20 ± 0.21 | 1.15 ± 0.19 | 1.47 ± 0.41 | 0.489 |
Renal Doppler US parameters in patients with liver cirrhosis according to MELD score.
| Parameter | MELD |
| Mean | SD | 95% confidence interval for mean | Minimum | Maximum |
| MELD score (8–46) | |
|---|---|---|---|---|---|---|---|---|---|---|
| Lower bound | Upper bound | Correlation ( | ||||||||
| <20 | 55 | 32.30 | 7.13 | 30.38 | 34.23 | 19.90 | 49.10 | |||
| RRA-MnV | >20 | 12 | 28.47 | 7.88 | 23.46 | 33.47 | 13.80 | 39.90 | NS |
−0.396
|
| Total | 67 | 31.62 | 7.36 | 29.82 | 33.41 | 13.80 | 49.10 | |||
|
| ||||||||||
| <20 | 55 | 31.37 | 7.15 | 29.43 | 33.30 | 17.10 | 49.90 | |||
| LRA-MnV | >20 | 12 | 29.89 | 9.73 | 23.71 | 36.08 | 14.90 | 53.50 | NS |
−0.294
|
| Total | 67 | 31.10 | 7.61 | 29.25 | 32.96 | 14.90 | 53.50 | |||
|
| ||||||||||
| <20 | 55 | 19.80 | 5.14 | 18.41 | 21.19 | 11.30 | 32.30 | |||
| RRA-EDV | >20 | 12 | 15.71 | 5.46 | 12.24 | 19.18 | 6.80 | 24.20 | 0.016 |
−0.459
|
| Total | 67 | 19.07 | 5.40 | 17.75 | 20.39 | 6.80 | 32.30 | |||
|
| ||||||||||
| <20 | 55 | 18.51 | 4.75 | 17.22 | 19.79 | 10.20 | 30.70 | |||
| LRA-EDV | >20 | 12 | 16.61 | 7.48 | 11.86 | 21.36 | 6.90 | 35.20 | NS |
−0.358
|
| Total | 67 | 18.17 | 5.33 | 16.87 | 19.47 | 6.90 | 35.20 | |||
|
| ||||||||||
| <20 | 55 | 0.65 | 0.05 | 0.63 | 0.66 | 0.56 | 0.79 | |||
| RRA-RI | >20 | 12 | 0.73 | 0.07 | 0.68 | 0.77 | 00.65 | 0.86 | 0.0001 |
0.552
|
| Total | 67 | 0.66 | 0.06 | 0.65 | 0.68 | 0.56 | 0.86 | |||
|
| ||||||||||
| <20 | 55 | 0.66 | 0.06 | 0.64 | 0.67 | 0.53 | 0.77 | |||
| LRA-RI | >20 | 12 | 0.74 | 0.07 | 0.69 | 0.78 | 0.61 | 0.82 | 0.0001 |
0.477
|
| Total | 67 | 0.67 | 0.07 | 0.66 | 0.69 | 0.53 | 0.82 | |||
|
| ||||||||||
| <20 | 55 | 1.13 | 0.17 | 1.08 | 1.17 | 0.87 | 1.57 | |||
| RRA-PI | >30 | 12 | 1.56 | 0.47 | 1.27 | 1.86 | 1.13 | 2.62 | 0.0001 |
0.604
|
| Total | 67 | 1.21 | 0.30 | 1.13 | 1.28 | 0.87 | 2.62 | |||
|
| ||||||||||
| <20 | 55 | 1.16 | 0.19 | 1.11 | 1.22 | 0.78 | 1.78 | |||
| LRA-PI | >30 | 12 | 1.56 | 0.35 | 1.33 | 1.78 | 1.01 | 2.22 | 0.0001 |
0.564
|
| Total | 67 | 1.23 | 0.27 | 1.17 | 1.30 | 0.78 | 2.22 | |||
Figure 1The values of RRA/LRA-MnV, RRA/LRA-PSV and RRA/LRA-EDV in patients with presence or absence of esophageal varices.
Figure 2The values of RRA/LRA-EDV in patients with compensated and decompensated liver cirrhosis.
Figure 3The values of RRA/LRA-RI in patients with compensated and decompensated liver cirrhosis.
Figure 4The values of RRA/LRA-PI in patients with compensated and decompensated liver cirrhosis.
Figure 5The values of RRA/LRA-MnV and RRA/LRA-EDV in patients with presence or absence of ascites.
Figure 6The values of RRA/LRA-RI in patients with presence or absence of hepatic encephalopathy.
Figure 7The values of RRA/LRA-PI in patients with presence or absence of hepatic encephalopathy.
Significant correlations between liver and renal Doppler US parameters.
| Surrogate markers of renal function | Parameters | Pearson correlation |
|
|---|---|---|---|
| RRA-MnV | 0.252 | 0.040 | |
| HA-PSV | RRA-PSV | 0.347 | 0.004 |
| LRA-PSV | 0.363 | 0.003 | |
|
| |||
| RRA-MnV | 0.250 | 0.041 | |
| HA-MnV | RRA-PSV | 0.343 | 0.005 |
| LRA-PSV | 0.355 | 0.003 | |
|
| |||
| RRA-MnV | 0.278 | 0.023 | |
| LRA-MnV | 0.266 | 0.030 | |
| HA-EDV | RRA-EDV | 0.301 | 0.013 |
| RRA-EDV | 0.287 | 0.019 | |
| LRA-PSV | 0.267 | 0.029 | |
|
| |||
| RRA-RI | 0.446 | 0.0001 | |
| LRA-RI | 0.528 | 0.0001 | |
| HA-RI | RRA-PI | 0.387 | 0.001 |
| LRA-RI | 0.451 | 0.001 | |
| LRA-EDV | −0.250 | 0.041 | |
|
| |||
| RRA-PSV | 0.244 | 0.047 | |
| RRA-RI | 0.416 | 0.0001 | |
| HA-PI | LRA-RI | 0.477 | 0.0001 |
| RRA-PI | 0.344 | 0.004 | |
| LRA-RI | 0.394 | 0.001 | |
|
| |||
| A/P | RRA-PSV | 0.284 | 0.020 |
Significant correlations between surrogate markers of renal function and Childs and MELD scores, and renal Doppler US parameters.
| Surrogate markers of renal function | Parameters | Pearson correlation |
|
|---|---|---|---|
| Serum urea | Child's score | 0.353 | 0.012 |
| MELD score | 0.435 | 0.002 | |
| LRA-MnV | −0.294 | 0.036 | |
| LRA-EDV | −0.313 | 0.025 | |
| RRA-RI | 0.297 | 0.035 | |
| RRA-PI | 0.296 | 0.035 | |
| LRA-PI | 0.280 | 0.046 | |
|
| |||
| Serum creatinine | RRA-MnV | −0.346 | 0.005 |
| LRA-MnV | −0.326 | 0.008 | |
| RRA-EDV | −0.350 | 0.004 | |
| LRA-EDV | −0.317 | 0.010 | |
|
| |||
| Serum sodium | Child's score | −0.423 | 0.001 |
| MELD score | −0.485 | 0.0001 | |